Your browser doesn't support javascript.
loading
Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial.
Naimi, Rahim M; Hvistendahl, Mark; Enevoldsen, Lotte H; Madsen, Jan L; Fuglsang, Stefan; Poulsen, Steen S; Kissow, Hannelouise; Pedersen, Jens; Nerup, Nikolaj; Ambrus, Rikard; Achiam, Michael P; Svendsen, Lars B; Holst, Jens J; Hartmann, Bolette; Hansen, Svend H; Dragsted, Lars O; Steensberg, Adam; Mouritzen, Ulrik; Hansen, Mark B; Jeppesen, Palle B.
Affiliation
  • Naimi RM; Department of Medical Gastroenterology and Hepatology, Rigshospitalet, Copenhagen, Denmark. Electronic address: rahim.mohammad.naimi@regionh.dk.
  • Hvistendahl M; Department of Medical Gastroenterology and Hepatology, Rigshospitalet, Copenhagen, Denmark.
  • Enevoldsen LH; Department of Clinical Physiology, Nuclear Medicine, and PET, Rigshospitalet, Copenhagen, Denmark.
  • Madsen JL; Department of Clinical Physiology and Nuclear Medicine, Centre for Functional and Diagnostic Imaging and Research, Hvidovre Hospital, Hvidovre, Denmark.
  • Fuglsang S; Department of Clinical Physiology and Nuclear Medicine, Centre for Functional and Diagnostic Imaging and Research, Hvidovre Hospital, Hvidovre, Denmark.
  • Poulsen SS; Department of Biomedical Sciences, The Panum Institute, University of Copenhagen, Copenhagen, Denmark.
  • Kissow H; Novo Nordisk Foundation Centre of Basic Metabolic Research and Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Pedersen J; Novo Nordisk Foundation Centre of Basic Metabolic Research and Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Nerup N; Department of Surgical Gastroenterology, Rigshospitalet, Copenhagen, Denmark.
  • Ambrus R; Department of Surgical Gastroenterology, Rigshospitalet, Copenhagen, Denmark.
  • Achiam MP; Department of Surgical Gastroenterology, Rigshospitalet, Copenhagen, Denmark.
  • Svendsen LB; Department of Surgical Gastroenterology, Rigshospitalet, Copenhagen, Denmark.
  • Holst JJ; Novo Nordisk Foundation Centre of Basic Metabolic Research and Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Hartmann B; Novo Nordisk Foundation Centre of Basic Metabolic Research and Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Hansen SH; Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.
  • Dragsted LO; Department of Nutrition, Exercise, and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
  • Steensberg A; Research and Development, Zealand Pharma, Glostrup, Denmark.
  • Mouritzen U; Research and Development, Zealand Pharma, Glostrup, Denmark.
  • Hansen MB; Research and Development, Zealand Pharma, Glostrup, Denmark.
  • Jeppesen PB; Department of Medical Gastroenterology and Hepatology, Rigshospitalet, Copenhagen, Denmark.
Lancet Gastroenterol Hepatol ; 4(5): 354-363, 2019 05.
Article in En | MEDLINE | ID: mdl-30880176

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Short Bowel Syndrome / Gastrointestinal Agents / Glucagon-Like Peptide 2 / Intestinal Absorption Type of study: Clinical_trials / Guideline Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Gastroenterol Hepatol Year: 2019 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Short Bowel Syndrome / Gastrointestinal Agents / Glucagon-Like Peptide 2 / Intestinal Absorption Type of study: Clinical_trials / Guideline Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Gastroenterol Hepatol Year: 2019 Type: Article